← Human Trials & Peer-Reviewed Studies

Supplementation with vitamin D or ω-3 fatty acids in adolescent girls and young women with endometriosis (SAGE): a double-blind, randomized, placebo-controlled trial.

Plain-language guide to PMID 32453393 (2020): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc, endometriosis.

Key Facts

PMID
32453393
Journal
The American journal of clinical nutrition
Year
2020
Study type
Randomized Controlled Trial
Authors
Nodler JL et al. (9 authors)
DOI
10.1093/ajcn/nqaa096
Registered trial
NCT02387931

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc in the context of endometriosis.

The researchers aimed to determine whether supplementation with vitamin D or ω-3 fatty acids remediates pain, changes frequency of pain medication usage, or affects quality of life in young women with endometriosis.

Why It Was Studied

Adolescents with endometriosis are a particularly underserved population who struggle with chronic pain.

Despite widespread use, there are no published trials examining the individual effects of vitamin D and omega-3 (n-3) fatty acid supplementation on endometriosis-associated pain in adolescents.

Who Took Part

The age groups tagged for this paper are teenagers, young adults and adults, women only.

Women (aged 12-25 y) with surgically confirmed endometriosis and pelvic pain enrolled in a double-blind, randomized, placebo-controlled trial.

How the Study Was Run

The researchers set it up as a randomized, double-blind and placebo-controlled study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Blinding on both sides kept the participants and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.

Some participants received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.

The primary outcome was pain measured by the visual analog scale (VAS).

Secondary outcomes were quality of life, pain catastrophizing, and pain medication usage.

What Was Measured

PubMed files the paper under topics including Cholecalciferol, Dietary Supplements, Endometriosis, Fatty Acids, Omega-3, Pelvic Pain, Placebo Effect and Quality of Life.

Author keywords: adolescents, omega-3 fatty acids, randomized controlled trial and vitamin D.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in people with endometriosis.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2020 (The American journal of clinical nutrition), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, Endometriosis research.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.